search
Back to results

Effect of 3 Years of Exercise on Development of Atrial Fibrillation

Primary Purpose

Atrial Fibrillation

Status
Active
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
High intensity exercise
Moderate intensity exercise
Control
Sponsored by
Norwegian University of Science and Technology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Atrial Fibrillation focused on measuring Atrial fibrillation, Prevention, Exercise

Eligibility Criteria

70 Years - 75 Years (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Participating in the "Generation 100" study

Exclusion Criteria:

-

Sites / Locations

  • Norwegian University of Science and Technology

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

High intensity exercise

Moderate intensity exercise

Control group

Arm Description

High intensity exercise(Borg 16) in intervals.

Moderate intensity exercise 3 times a week.

Exercise on their own. Follow current guidelines.

Outcomes

Primary Outcome Measures

Number of persons who develop atrial fibrillation during the 3 year intervention period
People who already have the diagnosis before randomisation will not be counted.

Secondary Outcome Measures

Number of persons who develop atrial fibrillation during the 6 years after randomisation

Full Information

First Posted
September 4, 2012
Last Updated
September 16, 2022
Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01680302
Brief Title
Effect of 3 Years of Exercise on Development of Atrial Fibrillation
Official Title
Effect of 3 Years of Exercise on Development of Atrial Fibrillation - A "Generation 100" Substudy
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 2012 (Actual)
Primary Completion Date
June 2023 (Anticipated)
Study Completion Date
June 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a substudy of "Generation 100". In that study, 4000 healthy persons between 70 and 75 will be randomised to a moderate intensity training group, a high intensity training group or control group, with 3 years of exercise. The investigators will follow these persons and register all who develop atrial fibrillation during these 3 years, and at follow-up after ended intervention to see if there is differences in the number of persons who develop atrial fibrillation in the 3 groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
Keywords
Atrial fibrillation, Prevention, Exercise

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
1567 (Actual)

8. Arms, Groups, and Interventions

Arm Title
High intensity exercise
Arm Type
Experimental
Arm Description
High intensity exercise(Borg 16) in intervals.
Arm Title
Moderate intensity exercise
Arm Type
Experimental
Arm Description
Moderate intensity exercise 3 times a week.
Arm Title
Control group
Arm Type
Experimental
Arm Description
Exercise on their own. Follow current guidelines.
Intervention Type
Behavioral
Intervention Name(s)
High intensity exercise
Intervention Type
Behavioral
Intervention Name(s)
Moderate intensity exercise
Intervention Type
Behavioral
Intervention Name(s)
Control
Intervention Description
Advised to follow current guidelines for physical activity, but exercise on their own.
Primary Outcome Measure Information:
Title
Number of persons who develop atrial fibrillation during the 3 year intervention period
Description
People who already have the diagnosis before randomisation will not be counted.
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Number of persons who develop atrial fibrillation during the 6 years after randomisation
Time Frame
6 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Participating in the "Generation 100" study Exclusion Criteria: -
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Paal Loennechen, PhD
Organizational Affiliation
St. Olavs Hospital
Official's Role
Study Chair
Facility Information:
Facility Name
Norwegian University of Science and Technology
City
Trondheim
ZIP/Postal Code
7491
Country
Norway

12. IPD Sharing Statement

Learn more about this trial

Effect of 3 Years of Exercise on Development of Atrial Fibrillation

We'll reach out to this number within 24 hrs